HER2-overexpression/amplification and survival in patients with resectable esophageal/gastroesophageal junction adenocarcinoma (E/GEJ-AC) treated with neoadjuvant carboplatin/paclitaxel-based chemoradiation.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Yening Feng, Cristobal Tomas Sanhueza Condell, Christopher Leigh Hallemeier, Shanda H Blackmon, Joleen M. Hubbard, Thorvardur Ragnar Halfdanarson, Timothy J. Hobday, Stephen D. Cassivi, Robert Shen, Michelle A. Neben-Wittich, Francis C Nichols, Kenneth Merrell, Ellen w Blanco, Robert R. McWilliams, Steven R Alberts, Henry C. Pitot, Aminah Jatoi, Michael G. Haddock, Dennis A. Wigle, Harry H. Yoon
Institution: Mayo Clinic
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3124578085